logo-loader
viewKromek Group PLC

Kromek Group fully focused on commercialisation; on track to achieve revenue growth

Dr Arnab Basu, the chief executive officer of Kromek Group PLC (LON:KMK), spoke to Proactive London following the release of its interm results to October 2018.

Basu says they're on track to achieve revenue growth and in-line underlying earnings (EBITDA) over the full year.

He adds visibility of revenue for the next six to 24 months continues to increase, which includes visibility of around 86% of the forecast revenue for 2018/19.

Quick facts: Kromek Group PLC

Price: 17.25 GBX

AIM:KMK
Market: AIM
Market Cap: £59.45 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Kromek Group PLC named herein, including the promotion by the Company of Kromek Group PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Lekoil agrees deal to drill up to five new wells in Nigeria

Top stories from the Proactive Investors UK newsroom. Kromek (LON:KMK) has been awarded three contracts worth £1.6mln for its D3S platform for nuclear radiation detection. The largest contract, worth £1.1mln, is with a UK government-related company. Avation (LON:AVAP) has seen another...

on 1/7/19

2 min read